Ayala Pharmaceuticals Inc (ADXS)

[exel_mm]

We'll likely never know unless there is a M&A soon - that would be the validation. Other than that, it could have been inappropriate behavior (highly unlikely) OR disagreement on direction OR simply accountability for performance related to the pps. Maybe a combination of all of the above.

From what we know (here say), he seemed surprised by his removal, so it's probably simply a change in direction where he may not align. This is why I believe we're heading to a M&A for somewhere above 2.5B.